Important NoticeThis app is for educational purposes only. You must be 18+ to use it. We do not sell any peptides on this site.

Peptide Library / Detail
Half-life
Estimated 1-3 hours (typical for short tripeptides)
Delivery
Subcutaneous or intramuscular injection
Dosage
—
Research Use Only
All products listed are for laboratory research only — not for human consumption. By browsing, you acknowledge these terms.
Cartalax is a synthetic tripeptide (Ala-Glu-Asp) developed as part of the Khavinson peptide bioregulator family. It is designed to support tissue regeneration and cellular function, particularly in cartilage, musculoskeletal tissues, and aging organs. Research suggests it may modulate gene expression and influence stem cell differentiation and proliferation processes.
Research protocols typically involve subcutaneous or intramuscular administration at doses ranging from 10-20 mcg per injection, administered 1-2 times daily for cycles of 10-20 days. Some protocols suggest periodic cycling (e.g., 10 days on, 10 days off) to support tissue repair and regeneration processes.
Cartalax functions as a bioregulatory peptide that influences gene expression patterns in aging cells and tissues. It appears to modulate mesenchymal stem cell differentiation and proliferation, enhance cellular renewal processes in various tissues including kidney and skin, and regulate thymocyte function. The tripeptide structure allows it to interact with cellular signaling pathways involved in tissue homeostasis and regeneration.
Cartalax is a synthetic tripeptide (Ala-Glu-Asp) developed as part of the Khavinson peptide bioregulator family. It is designed to support tissue regeneration and cellular function, particularly in cartilage, musculoskeletal tissues, and aging organs. Research suggests it may modulate gene expression and influence stem cell differentiation and proliferation processes.
Cartalax has an approximate half-life of Estimated 1-3 hours (typical for short tripeptides). The half-life determines how often you need to inject to maintain steady blood levels — use the Peptides Calculator half-life calculator to plot your specific dosing schedule and see the decay curve.
Cartalax is typically delivered via subcutaneous or intramuscular injection. The Peptides Calculator app helps you reconstitute the vial with bacteriostatic water, calculate your exact dose in syringe units, and track each injection.
Cartalax functions as a bioregulatory peptide that influences gene expression patterns in aging cells and tissues. It appears to modulate mesenchymal stem cell differentiation and proliferation, enhance cellular renewal processes in various tissues including kidney and skin, and regulate thymocyte function. The tripeptide structure allows it to interact with cellular signaling pathways involved in tissue homeostasis and regeneration.
Studied benefits of Cartalax include: Supports cartilage and connective tissue regeneration, May enhance mesenchymal stem cell function and differentiation, Promotes cellular renewal in aging tissues, Supports musculoskeletal tissue repair and maintenance, May improve tissue function in aging organs including kidney and thymus, Modulates gene expression patterns associated with cellular aging, Supports skin fibroblast function during aging processes. These are research findings only — Peptides Calculator does not provide medical advice; consult a qualified healthcare professional before starting any peptide protocol.
Reported side effects of Cartalax include: Limited adverse effects reported in research literature, Potential injection site reactions (redness, mild discomfort), Individual sensitivity or allergic reactions possible, Long-term safety profile requires further investigation. Always discuss potential side effects with a licensed healthcare provider before using any research peptide.
Other recovery compounds in the Peptides Calculator library.
Half-life · Approximately 1-2 hours (estimated based on similar short peptides)
Half-life · Not extensively characterized; short peptides typically have half-lives of minutes to hours
Half-life · Approximately 30-60 minutes (varies by delivery method and formulation)
Half-life · 30-60 minutes
Half-life · Approximately 2-3 hours
Half-life · Unknown - insufficient pharmacokinetic data